Pharma & Biotech

Biotechnology firm Codexis finds itself navigating a critical transition. Recent quarterly results paint a picture of significant revenue contraction, even...

Biotechnology firm Ocugen is facing intense selling pressure, with its stock price declining sharply in recent sessions. On Monday, the...

IO Biotech finds itself at a pivotal moment. As CEO Mai-Britt Zocca addresses investors at the Evercore Healthcare Conference, the...

The battle for dominance in the lucrative weight-loss drug sector is heating up. In a bold strategic move, Eli Lilly...

The Danish pharmaceutical giant Novo Nordisk finds itself navigating a period of significant market turbulence. Investor sentiment, already battered by...

InnoCan Pharma is facing a severe market downturn. Trading opened this week with shares collapsing by over 14%, settling at...

December has opened with a jolt for BioNTech and its investors. A strategic pivot toward oncology and a critical acquisition...

Despite a steady dividend and positive clinical trial news, AbbVie's stock price has struggled to gain momentum. This creates a...

The competitive landscape for treating Stargardt disease has intensified following a significant clinical announcement. While Ocugen continues developing its novel...

Investor nerves are being tested as shares in Healwell AI exhibit extreme volatility, trading dangerously close to a pivotal support...